Call Now Open
2025 Oxford-Harrington Rare Disease Scholar Award
Rare / Orphan, Oncology
Engineering Chimeric Antigen Receptors Fused to a High-Efficiency Lenalidomide-Degradable Tag to Control CAR-T Cell Activity - iTAG3
2024 Oxford-Harrington Rare Disease Scholar
Full profile coming soon.